Ofer Kobo1,2, Sherry-Ann Brown3, Tarek Nafee4, Mohamed O Mohamed2, Kamal Sharma5, Sedralmontaha Istanbuly6, Ariel Roguin1,2, Richard K Cheng7, Mamas A Mamas2,8. 1. Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel. 2. Keele Cardiovascular Research Group, Keele University, Stoke on Trent, United Kingdom. 3. Cardio-Oncology Program, Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. 4. Department of Medicine, Roger Williams Medical Center, Boston University School of Medicine, Boston, MA, USA. 5. U.N. Mehta ICRC, B. J. Medical College, Ahmedabad, India. 6. Faculty of Medicine, University of Aleppo, Aleppo, Syrian Arab Republic. 7. Division of Cardiology, University of Washington Heart Institute, Seattle, WA, USA. 8. Institute of Population Health, University of Manchester, Manchester, United Kingdom.
Abstract
OBJECTIVE: To describe the patient characteristics and the reason for admission of patients with malignancy by malignancy, and to study mortality rates for the different causes of admissions among the different types of cancer. PATIENTS AND METHODS: Using the nationwide Inpatient Sampling (2015-2017) we examined the cause of admission and associated in-hospital mortality, stratified by presence and type of malignancy. Multivariable logistic regression models were used to examine the association between in-hospital mortality and malignancy sites for different primary admission causes. RESULTS: Out of 67 819 693 inpatient admissions, 8.8% had malignancy. Amongst those with malignancy, haematological malignancy was the most common (20.2%). The most common cause of admission amongst all cancers were malignancy-related admissions, where up to 57% of all colorectal admissions were malignancy-related. The most common non-malignancy cause of admission was infectious causes, which were most frequent among patients with haematological malignancy (18.4%). Patients with malignancy had higher crude mortality rates (5.7% vs 1.9%). Mortality rates were highest among patients with lung cancer (8.7%). Among all admissions, the adjusted rates of mortality were higher for patients with lung (OR 3.65, 95% CI [3.59-3.71]), breast (OR 2.06, 95% CI [1.99-2.13]), haematological (OR 1.79, 95% CI [1.76-1.82]) and colorectal (OR 1.71, 95% CI [1.66-1.76]) malignancies compared with patients with no malignancy. CONCLUSION: Our work highlights the need to consider the burden of cancer on our hospital services and consider how the prognostic impact of different types of admissions may relate to the type of cancer diagnosis and understand whether these differences relate to disparities in clinical care/treatments.
OBJECTIVE: To describe the patient characteristics and the reason for admission of patients with malignancy by malignancy, and to study mortality rates for the different causes of admissions among the different types of cancer. PATIENTS AND METHODS: Using the nationwide Inpatient Sampling (2015-2017) we examined the cause of admission and associated in-hospital mortality, stratified by presence and type of malignancy. Multivariable logistic regression models were used to examine the association between in-hospital mortality and malignancy sites for different primary admission causes. RESULTS: Out of 67 819 693 inpatient admissions, 8.8% had malignancy. Amongst those with malignancy, haematological malignancy was the most common (20.2%). The most common cause of admission amongst all cancers were malignancy-related admissions, where up to 57% of all colorectal admissions were malignancy-related. The most common non-malignancy cause of admission was infectious causes, which were most frequent among patients with haematological malignancy (18.4%). Patients with malignancy had higher crude mortality rates (5.7% vs 1.9%). Mortality rates were highest among patients with lung cancer (8.7%). Among all admissions, the adjusted rates of mortality were higher for patients with lung (OR 3.65, 95% CI [3.59-3.71]), breast (OR 2.06, 95% CI [1.99-2.13]), haematological (OR 1.79, 95% CI [1.76-1.82]) and colorectal (OR 1.71, 95% CI [1.66-1.76]) malignancies compared with patients with no malignancy. CONCLUSION: Our work highlights the need to consider the burden of cancer on our hospital services and consider how the prognostic impact of different types of admissions may relate to the type of cancer diagnosis and understand whether these differences relate to disparities in clinical care/treatments.
Authors: Kathleen M Sturgeon; Lei Deng; Shirley M Bluethmann; Shouhao Zhou; Daniel M Trifiletti; Changchuan Jiang; Scott P Kelly; Nicholas G Zaorsky Journal: Eur Heart J Date: 2019-12-21 Impact factor: 29.983
Authors: Aditya Bharadwaj; Jessica Potts; Mohamed O Mohamed; Purvi Parwani; Pooja Swamy; Juan C Lopez-Mattei; Muhammad Rashid; Chun Shing Kwok; David L Fischman; Vassilios S Vassiliou; Philip Freeman; Erin D Michos; Mamas A Mamas Journal: Eur Heart J Date: 2020-06-14 Impact factor: 29.983
Authors: N G Zaorsky; T M Churilla; B L Egleston; S G Fisher; J A Ridge; E M Horwitz; J E Meyer Journal: Ann Oncol Date: 2017-02-01 Impact factor: 32.976
Authors: Mohamed O Mohamed; Harriette G C Van Spall; Evangelos Kontopantelis; Mohamad Alkhouli; Ana Barac; Islam Y Elgendy; Safi U Khan; Chun Shing Kwok; Ahmad Shoaib; Deepak L Bhatt; Mamas A Mamas Journal: Eur Heart J Acute Cardiovasc Care Date: 2021-02-04
Authors: Laura Panattoni; Catherine Fedorenko; Mikael Anne Greenwood-Hickman; Karma Kreizenbeck; Julia R Walker; Renato Martins; Keith D Eaton; John W Rieke; Ted Conklin; Bruce Smith; Gary Lyman; Scott D Ramsey Journal: J Oncol Pract Date: 2018-02-08 Impact factor: 3.840
Authors: Joann Hsu; John P Donnelly; Justin Xavier Moore; Karen Meneses; Grant Williams; Henry E Wang Journal: Am J Emerg Med Date: 2018-03-13 Impact factor: 2.469
Authors: Fabio Silvio Taccone; Antonio A Artigas; Charles L Sprung; Rui Moreno; Yasser Sakr; Jean-Louis Vincent Journal: Crit Care Date: 2009-02-06 Impact factor: 9.097